What will be Felzartamab's market share within its first year of launch? | Categorical | | | 7 months ago | |
Will Biogen achieve all milestone payments for the HI-Bio acquisition by end of 2026? | Binary | | | 7 months ago | |
Will Felzartamab be approved by the FDA by end of 2025? | Binary | | | 7 months ago | |
Biogen completes HI-Bio acquisition by year-end? | Binary | | | 7 months ago | |
Felzartamab approved by FDA by end of 2025? | Binary | | | 7 months ago | |
Biogen stock up 20% six months post-HI-Bio deal? | Binary | | | 7 months ago | |
Total HI-Bio milestone payments by Biogen by end of 2025 | Categorical | | | 7 months ago | |
How will HI-Bio's integration impact Biogen's revenue by the end of 2025? | Categorical | | | 7 months ago | |
How will Biogen's stock price react the day after the HI-Bio acquisition announcement? | Categorical | | | 7 months ago | |
Will Biogen's stock price increase within 6 months following the HI-Bio acquisition announcement? | Binary | | | 7 months ago | |
Status of HI-Bio integration into Biogen by end of 2025 | Categorical | | | 7 months ago | |
Market reaction to Biogen's acquisition of HI-Bio one week post-announcement | Categorical | | | 7 months ago | |
